Conversations in CLL
Conversations in CLL provides an in-depth look at novel treatments and new studies. Check in frequently for exclusive video interviews, Q&A’s and expert commentary on key issues facing clinicians today.
Related Articles
Selinexor Plus Ruxolitinib Displays Activity in Ruxolitinib-Pretreated Myelofibrosis
Selinexor plus ruxolitinib showed activity in patients with myelofibrosis who were treated with ruxolitinib.
Immune reconstitution and evolution of B-cell–stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL
Key PointsLymphopenia is transient with a persistent lack of effector B cells causing no excess late infectious mortality after R-CHOP for HIV-DLBCL.R-IPI,
Daratumumab Significantly Improves PFS, Extends OS in Smoldering Myeloma
Subcutaneous daratumumab reduced the risk for disease progression or death vs active monitoring in intermediate- or high-risk smoldering multiple myeloma.
Behind the Scenes: Patient Education and Decision-Making for CAR T
Panelists discuss how health care providers engage in vital conversations with patients about CAR T therapy, focusing on comprehensive education, emotional support, and clear communication…
Stay Updated: December 2024 News from AHNS – Corrected Meeting Dates!
Email from American Head and Neck Society This year, many of our AHNS Sections and Services have been working tirelessly to deliver top-notch educational…
The OncFive: Top Oncology Articles for the Week of 12/15
The FDA awards accelerated approval to encorafenib regimen in BRAF V600E+ CRC, ensartinib wins approval in ALK+ non–small cell lung cancer, and more.
Endometrial Cancer Classification and Management in the Molecular Subtyping Era
A 65-year-old woman presented with a 6-month history of postmenopausal vaginal bleeding, and endometrial biopsy showed grade 2 endometrioid adenocarcinoma. What would you do next?
New Developments in CAR T Treatments Webinar Infographic Series
The following infographics are based on New Developments in CAR T Treatments Webinar Series, which aired on Tuesday, September 10, at 12 p.m. CDT and featured…
Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer
This cohort study assesses the feasibility and safety of a community-based magnetic resonance imaging (MRI) diagnostic strategy in men with suspected prostate cancer using 3-year…